Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M

Open source

DOI: 10.1056/nejmoa1200690
Published: 2012 Jun 28
Container: The New England journal of medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa1200690,
  title = {Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.},
  author = {Topalian SL and Hodi FS and Brahmer JR and Gettinger SN and Smith DC and McDermott DF and Powderly JD and Carvajal RD and Sosman JA and Atkins MB and Leming PD and Spigel DR and Antonia SJ and Horn L and Drake CG and Pardoll DM and Chen L and Sharfman WH and Anders RA and Taube JM and McMiller TL and Xu H and Korman AJ and Jure-Kunkel M and Agrawal S and McDonald D and Kollia GD and Gupta A and Wigginton JM and Sznol M},
  year = {2012},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa1200690},
  url = {https://doi.org/10.1056/nejmoa1200690}
}

RIS

TY  - JOUR
TI  - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
AU  - Topalian SL
AU  - Hodi FS
AU  - Brahmer JR
AU  - Gettinger SN
AU  - Smith DC
AU  - McDermott DF
AU  - Powderly JD
AU  - Carvajal RD
AU  - Sosman JA
AU  - Atkins MB
AU  - Leming PD
AU  - Spigel DR
AU  - Antonia SJ
AU  - Horn L
AU  - Drake CG
AU  - Pardoll DM
AU  - Chen L
AU  - Sharfman WH
AU  - Anders RA
AU  - Taube JM
AU  - McMiller TL
AU  - Xu H
AU  - Korman AJ
AU  - Jure-Kunkel M
AU  - Agrawal S
AU  - McDonald D
AU  - Kollia GD
AU  - Gupta A
AU  - Wigginton JM
AU  - Sznol M
PY  - 2012
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa1200690
UR  - https://doi.org/10.1056/nejmoa1200690
ER  -

APA

SL, T., FS, H., JR, B., SN, G., DC, S., DF, M., JD, P., RD, C., JA, S., MB, A., PD, L., DR, S., SJ, A., L, H., CG, D., DM, P., L, C., WH, S., RA, A., JM, T., TL, M., H, X., AJ, K., M, J., S, A., D, M., GD, K., A, G., JM, W., & M, S. (2012). Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.. The New England journal of medicine. https://doi.org/10.1056/nejmoa1200690

Source records

pubmed · retrieved 2026-11-10T08:16:25.824Z